“…This is in agreement with results from computational modeling (Chao, et al, 2008) and clinical observations such as early age of onset and perfect co-segregation of mutation and disease. Also, MSI and the (Chialina, et al, 2006;Jenkins, et al, 2002;Leach, et al, 1993;Southey, et al, 2005). Similar to studies in yeast expressing the equivalent mutant protein, yMSH2-P640L (Drotschmann, et al, 1999;Polaczek, et al, 1998), we observed a strong mutator phenotype in Msh2 P622L/P622L ESCs.…”